C-reactive protein (CRP) and autoimmune disease: Facts and conjectures

Clinical and Developmental Immunology

Volumn 11, Issue 3-4, 2004, Pages 221-226

  Szalai, Alexander J ^a  

^a University of Alabama at Birmingham   (United States)

Author keywords

Apoptosis; EAE; Inflammation; Lupus; MS; SLE

Indexed keywords

AUTOANTIGEN; C REACTIVE PROTEIN; CALCIUM ION; PHOSPHORYLCHOLINE;

ANIMAL EXPERIMENT; ANTIGEN BINDING; APOPTOSIS; AUTOIMMUNE DISEASE; AUTOIMMUNITY; BINDING AFFINITY; COMPLEMENT ACTIVATION; CONFERENCE PAPER; HOMEOSTASIS; HOST RESISTANCE; INFLAMMATION; MOLECULAR WEIGHT; MOUSE; MULTIPLE SCLEROSIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; TRANSGENIC MOUSE;

ANIMALS; APOPTOSIS; AUTOIMMUNE DISEASES; C-REACTIVE PROTEIN; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MICE; MICE, TRANSGENIC; MODELS, IMMUNOLOGICAL;

EID: 7044232032     PISSN: 17402522     EISSN: None     Source Type: Journal    
DOI: 10.1080/17402520400001751     Document Type: Conference Paper

References (64)

1. Abernathy, T.J. and Avery, O.T. (1941) "The occurrence during acute infections of a protein not normally present in the blood. I. Distribution of the reactive protein in patient's sera and the effect of calcium on the flocculation reaction with C-polysaccharide of pneumococcus", J. Exp. Med. 73, 173-182.
2. Agrawal, A. and Volanakis, J.E. (1994) "Probing the Clq-binding site on human C-reactive protein by site-directed mutagenesis", J. Immunol. 152, 5404-5410.
3. Agrawal, A., Xu, Y., Ansardi, D., Macon, K.J. and Volanakis, J.E. (1992) "Probing the phosphocholine-binding site of human C-reactive protein by site-directed mutagenesis", J. Biol. Chem. 267, 25352-25358.
4. 76 and J. Immunol. 158, 345-350.
5. Agrawal, A., Shrive, A.K., Greenhough, T.J. and Volanakis, J.E. (2001) "Topology and structure of the Clq-binding site on C-reactive protein", J. Immunol. 166, 3998-4004.
6. Anderson, J.K., Stroud, R.M. and Volanakis, J.E. (1978) "Studies on the binding specificity of human C-reactive protein for phosphoryl- choline", Fed. Proc. 37, 1495.
7. Ballou, S.P. and Kushner, I. (1992) "C-reactive protein and the acute phase response", Adv. Intern. Med. 37, 313-336.
8. Berman, S., Gerwurz, H. and Mold, C. (1986) "Binding of C-reactive protein to nucleated cells leads to complement activation without cell lysis", J. Immunol. 136, 1354-1359.
9. Bharadwaj, D., Stein, M.P., Volzer, M., Mold, C. and Du Clos, T.W. (1999) "The major receptor for C-reactive protein on leukocytes is Fcγ receptor II", J. Exp. Med. 190, 585-590.
10. Bickerstaff, M.C., Botto, M., Hutchinson, W.L., Herbert, J., Tennent, G.A., Bybee, A., Mitchell, D.A., Cook, H.T., Butler, P.J., Walport, M.J. and Pepys, M.B. (1999) "Serum amyloid P component controls chromatin degradation and prevents antinuclear autoimmunity", Nat. Med. 5, 694-697.
11. Bodmer, B. and Siboo, R. (1977) "Isolation of mouse C-reactive protein from liver and serum", J. Immunol. 118, 1086-1089.
12. Burlingame, R.W., Volzer, M.A., Harris, J. and Du Clos, T.W. (1996) "The effects of acute phase proteins on clearance of chromatin from the circulation of normal mice", J. Immunol. 156, 4783-4788.
13. Ciliberto, G., Arcone, R., Wagner, E.F. and Rüther, U. (1987) "Inducible and tissue-specific expression of human C-reactive protein in transgenic mice", EMBO J. 6, 4017-4022.
14. Das, T., Sen, A., Kempf, T., Pramanik, S.R., Mandal, C. and Mandal, C. (2003) "Induction of glycosylation in human C-reactive protein under different pathological conditions", Biochem. J. 373, 345-355.
15. Du Clos, T.W. (1989) "C-reactive protein reacts with U1 small nuclear ribonucleoproteins", J. Immunol. 143, 2553-2559.
16. Du Clos, T.W., Zlock, L.T. and Rubin, R.L. (1988) "Analysis of the binding of C-reactive protein to histones and chromatin", J. Immunol. 141, 4266-4270.
17. 1 mice treated with C-reactive protein", Clin. Immunol. Immunopathol. 70, 22-27.
18. Emsley, J., White, H.E., O'Hara, B.P., Olivia, G., Srinivasan, N., et al. (1994) "Structure of pentameric human serum amyloid P component", Nature 367, 338-345.
19. Fischer, W. (2000) "Pneumococcal lipoteichoic and teichoic acids", In: Tomasz, A., ed., Streptococcus pneumoniae: Molecular Biology and Mechanisms of Disease (Mary Ann Liebert Inc., New York), pp 155-178.
20. Gabay, C., Roux-Lombard, P., de Moerloose, P., Dayer, J.M., Wischer, T. and Guerne, P.A. (1993) "Absence of correlation between interleukin 6 and C-reactive protein blood levels in systemic lupus erythematosus compared with rheumatoid arthritis", J. Rheumatol. 20, 815-821.
21. Gershov, D., Kim, S., Brot, N. and Elkon, K.B. (2000) "C-reactive protein binds to apoptotic cells, protects the cells from assembly of the terminal complement components, and sustains an antiinflammatory innate immune response: implications for systemic autoimmunity", J. Exp. Med. 192, 1353-1363.
22. Gerwurz, H., Zhang, X.H. and Lint, T.F. (1995) "Structure and function of the pentraxins", Curr. Opin. Immunol. 7, 54-64.
23. Hind, C.R.K., Collin, P.M., Baltz, M.L. and Pepys, M.B. (1985) "Human serum amyloid P component, a circulating lectin with specificity for the cyclic 4,6-pyruvate acetal of galactose", Biochem. J. 225, 107-111.
24. Hundt, M., Zielinska-Skowronek, M. and Schmidt, R.E. (2001) "Lack of specific receptors for C-reactive protein on white blood cells", Eur. J. Immunol. 31, 3475-3483.
25. Ichikawa, K., Liu, W., Zhao, L., Wang, Z., Liu, D., Ohtsuka, T., Zang, H., Mountz, J.D., Koopman, W.J., Kimberly, R.P. and Zhou, T. (2001) "Tumoricidal activity of a novel anti-human DR5 monoclonal antibody without hepatocytes toxicity", Nat. Med. 7, 954-960.
26. Jefferis, R. and Lund, J. (2002) "Interaction sites on human IgG-Fc for FcγR: current models", Immunol. Lett. 82, 57-65.
27. Klein, L., Klein, T., Rüther, U. and Kyewski, B. (1998) "CD4 T cell tolerance to human C-reactive protein, an inducible serum protein, is mediated by medullary thymic epithelium", J. Exp. Med. 188, 5-16.
28. Kushner, I. (1982) "The phenomenon of the acute phase response", Ann. N Y Acad. Sci. 389, 39-48.
29. Kushner, I. and Mackiewicz, A. (1993) "The acute phases response: an overview", In: Mackiewicz, A., Kushner, I. and Baumann, H., eds, Acute Phase Proteins. Molecular Biology, Biochemistry, and Clincial Applications (CRC Press, Boca Raton), pp 3-20.
30. Lee, R.T., Takagahara, I. and Lee, Y.C. (2002) "Mapping the binding areas of human C-reactive protein for phosphorylcholine and polycationic compounds", J. Biol. Chem. 277, 225-232.
31. Marnell, L.L., Mold, C., Volzer, M.A., Burlingame, R.W. and Du Clos, T.W. (1995) "C-reactive protein binds to FcγRI in transfected COS cells", J. Immunol. 155, 2185-2193.
32. Mee-Ree, C., Park, B.H., Kim, J.S., Rho, H.W., Park, J.W. and Kim, H.R. (2000) "Protective effect of C-reactive protein against the lethality induced by Vibrio vulnificus lipopolysaccharide", Microbiol. Immunol. 44, 335-340.
33. Minota, S., Morino, N., Sakurai, H., Yamada, A. and Yazaki, Y. (1993) "Interrelationship between autoepitope, DNA-binding domain, and CRP-binding domain on a histone H1 molecule", Clin. Immunol. Immunopathol. 66, 269-271.
34. Mold, C., Gurule, C., Otero, D. and Du Clos, T.W. (1996) "Complement-dependent binding of C-reactive protein complexes to human erythrocyte CRI", Clin. Immunol. Immunopathol. 81, 153-160.
35. Mold, C., Gewurz, H. and Du Clos, T.W. (1999) "Regulation of complement activation by C-reactive protein", Immunopharmacology 42, 23-30.
36. Mold, C., Gresham, H.D. and Du Clos, T.W. (2001) "Serum amyloid P component and C-reactive protein mediate phagocytosis through murine FcγRs", J. Immunol. 166, 1200-1205.
37. Morrow, D.A. and Ridker, P.M. (2000) "C-reactive protein, inflammation, and coronary risk", Med. Clin. N. Am. 84, 149-162.
38. Osmand, A.P., Friedenson, B., Gewurz, H., Painter, R.H., Hofmann, T. and Shelton, E. (1977) "Characterization of C-reactive protein and the complement subcomponent Clt as homologous proteins displaying cyclic pentameric symmetry (pentraxins)", Proc. Natl Acad. Sci. USA 74, 739-743.
39. Pepys, M.B. and Baltz, M.I. (1983) "Acute phase proteins with special reference to C-reactive protein and related proteins (pentraxins) and serum amyloid A protein", Adv. Immunol. 34, 141-211.
40. Pepys, M.B., Baltz, M.L., Gomer, K., Davies, A.J.S. and Doenhoff, M. (1979) "Serum amyloid P component is an acute-phase reactant in the mouse", Nature 278, 259-261.
41. Pepys, M.B., Lanham, J.G. and DeBeer, F.C. (1982) "C-reactive protein in SLE", Clin. Rheum. Dis. 8, 91-103.
42. Pereira, D.A., Silva, J.A., Elkon, K.B. and Hughes, G.R.V. (1980) "C-reactive protein levels in systemic lupus erythematosus: a classification criterion?", Arthritis Rheum. 23, 770-771.
43. Rekvig, O.P., Andreassen, K. and Moens, U. (1998) "Antibodies to DNA-towards an understanding of their origin and pathophysiological impact in systemic lupus erythematosus", Scand. J. Rheumatol. 27, 1-6.
44. Robey, F.A., Jones, K.D. and Steinberg, A.D. (1985) "C-reactive protein mediates the solubilization of nuclear DNA by complement in vitro", J. Exp. Med. 161, 1344-1356.
45. Schwalbe, R.A., Dahlbäck, B., Coe, J.E. and Nelsestuen, G.L. (1992) "Pentraxin family of proteins interact specifically with phosphorylcholine and/or phosphorylethanolamine", Biochemistry 31, 4907-4915.
46. Shrive, A.K., Cheetham, G.M.T., Holden, D., Myles, D.A.A., Turnell, W.G., et al. (1996) "Three dimensional structure of human C-reactive protein", Nat. Struct. Biol. 3, 346-354.
47. Stein, M.P., Mold, C. and Du Clos, T.W. (2000) "C-reactive protein binding to murine leukocytes requires Fcγ receptors", J. Immunol. 164, 1514-1520.
48. Szalai, A.J., Briles, D.E. and Volanakis, J.E. (1995) "Human C-reactive protein is protective against fatal Streptococcuspneumoniae infection in transgenic mice", J. Immunol. 155, 2557-2563.
49. Szalai, A.J., VanCott, J.L., McGhee, J.R., Volanakis, J.E. and Benjamin, W.H., Jr. (2000) "Human C-reactive protein is protective against fatal Salmonella enterica serovar typhimurium infection in transgenic mice", Infect. Immun. 68, 5652-5656.
50. Szalai, A.J., Nataf, S., Hu, X.Z. and Barnum, S.R. (2002) "Experimental allergic encephalomyelitis is inhibited in trangenic mice expressing C-reactive protein", J. Immunol. 168, 5792-5797.
51. 1 mice expressing a human C-reactive protein transgene", Arthritis Rheum. 48, 1602-1611.
52. Theofilopoulos, A.N. and Dixon, F.J. (1989) "Experimental murine systemic lupus erythematosus", In: Swanson, J. and Chengerman, K., eds, Animal Models of Disease (US Deptartment of Agriculture, Washington, DC), pp 121-202.
53. Tomasz, A. (1967) "Choline in the cell wall of a bacterium: novel type of polymer-linked choline in pneumococcus", Science 157, 694-697.
54. Van Molle, W., Denecker, G., Rodriguez, I., Brouckaert, P., Vandenabeele, P. and Libert, C. (1999) "Activation of caspases in lethal experimental hepatitis and prevention by acute phase proteins", J. Immunol. 163, 235-5241.
55. Volanakis, J.E. (1982a) "Complement activation by C-reactive protein complexes", Ann. N Y Acad. Sci. 389, 235-250.
56. Volanakis, J.E. (1982b) "Complement-induced solubilization of C-reactive protein-pneumococcal C-polysaccharide precipitates: evidence for covalent binding of complement proteins to C-reactive protein and pneumococcal C-polysaccharide", J. Immunol. 128, 2745-2750.
57. Volanakis, J.E. (1982c) "Complement activation by C-reactive protein complexes", Ann. N Y Acad. Sci. 389, 235-250.
58. Volanakis, J.E. and Kaplan, M.H. (1971) "Specificity of C-reactive protein for choline phosphate residues of pneumococcal C-polysaccharide", Proc. Soc. Exp. Biol. Med. 136, 612-661.
59. Volanakis, J.E. and Narkates, A.J. (1983) "Binding of human C4 to C-reactive protein-pneumococcal C-polysaccharide complexes during activation of the classical complement pathway", Mol. Immunol. 20, 1201-1207.
60. Vyse, T.J. and Kotzin, B.L. (1998) "Genetic susceptibility to systemic lupus erythematosus", Annu. Rev. Immunol. 16, 261-292.
61. Whitehead, A.S., Zahedi, K., Rits, M., Mortensen, R.F. and Lelias, J.M. (1990) "Mouse C-reactive protein: generation of complementary DNA clones, structural analysis, and induction of messenger RNA during inflammation", Biochem. J. 266, 283-290.
62. Wright, A. and Morrison, S.L. (1997) "Effect of glycosylation on antibody function: implications for genetic engineering", Trends Biotechnol. 15, 26-32.
63. Xu, Y., Szalai, A.J., Zhou, T., Zinn, K.R., Chaudhuri, T.R., Li, X., Koopman, W.J. and Kimberly, R.P. (2003) "FcγRs modulate cytotoxicity of anti-Fas antibodies: implications for agonistic antibody-based therapeutics", J. Immunol. 171, 562-568.
64. Young, B., Gleeson, M. and Cripps, A.W. (1991) "C-reactive protein: a critical review", Pathology 23, 118-124.